IMWG Series

The International Myeloma Working Group (IMWG) Conference Series: Making Sense of Treatment is a medical education program created by the International Myeloma Foundation (IMF) to bring lively expert discussion of important myeloma treatment issues into the homes and offices of viewers around the world via live webcast.

Jun
13
IMWG Conference Series: Stockholm, Sweden
https://www.myeloma.org/videos/stockholm-2018-what-role-mass-spectrometry-multiple-myeloma Patients, caregivers, and doctors around the world can view the IMF's popular livestream IMWG Conference Series, "Making Sense of Treatment" from the 2018 IMWG Summit at 6 a.m. EST on Wednesday, June 13. IMF Chairman Dr. Brian G.M. Durie, Dr. Sagar Lonial, and IMF Chief Medical Officer Dr. Joseph Mikhael will distill, debate, and discuss myeloma news from the Summit, from the European Hematological...
Jun
14
Stockholm 2018: CAR T-cell Therapy
In this video, IMF Chairman Brian G.M. Durie moderates a lively discussion about CAR T-cell therapy with Dr. Joseph Mikhael (IMF Chief Medical Officer) and Dr. Sagar Lonial (Emory University, Atlanta(...)
Jun
14
Stockholm 2018: New Drugs in Multiple Myeloma
In this video, IMF Chairman Brian G.M. Durie moderates a lively discussion about new drugs and drug combinations in the myeloma treatment landscape with Dr. Joseph Mikhael (IMF Chief Medical Officer(...)
Jun
14
Stockholm 2018: Cost of Care
Drs. Brian GM Durie, Joseph Mikhael, and Sagar Lonial discuss the cost of care for multiple myeloma.
Jun
14
Stockholm 2018: The Role of CRISPR Gene Editing
In this video, IMF Chairman Brian G.M. Durie moderates a lively discussion about the role of CRISPR gene-editing in the landscape of multiple myeloma treatment with Dr. Joseph Mikhael (IMF Chief(...)
Jun
14
Stockholm 2018: The Role of Mass Spectrometry in Multiple Myeloma
In this video, IMF Chairman Brian G.M. Durie moderates a lively discussion about mass spectrometry with Dr. Joseph Mikhael (IMF Chief Medical Officer) and Dr. Sagar Lonial (Emory University, Atlanta(...)
Jun
14
Stockholm 2018: Status of MRD Testing
​In this video, IMF Chairman Brian G.M. Durie moderates a lively discussion about the status of minimal residual (MRD) testing with Dr. Joseph Mikhael (IMF Chief Medical Officer) and Dr. Sagar Lonial(...)

Give Where Needed Most

$500
$250
$100
$50
other

Learn More

 

We would like to thank:

Amgen, Astellas Pharma, Binding Site, Bristol-Myers Squibb, Celgene, Diplomat Pharmacy, Genentech, Hoffmann-La Roche, Janssen, Karyopharm Therapeutics, Merck, Novartis, Oncopeptides, Sanofi-Genzyme, Takeda Oncology